Tech Company Financing Transactions
Invivodata Funding Round
Invivodata closed a $10 million funding round on 9/14/2006. Investors included River Cities Capital Funds.
Transaction Overview
Company Name
Announced On
9/14/2006
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
River Cities Capital Funds (Lead Investor) (Carter McNabb)
Proceeds Purpose
Company Information
Company Status
Acquired or Merged
Industry
Enterprise IT
Mailing Address
2100 Wharton Street 505
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Overview
Invivodata is the worldwide leader in capturing clinical trial data of the highest integrity directly from patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Arthur Stone
Chief Executive Officer
Doug Engfer
Chief Financial Officer
Gary Mitcheltree
Chief Operating Officer
Bob Young
Chief Scientific Officer
Saul Shiffman
VP - Customer Service
Jason Eger
VP - Operations
Wolfgang Summa
VP - Product Management
Jon McClelland
VP - Regulatory Affairs
Jean Paty
Browse more venture capital transactions:
Prev: 9/14/2006: Amicus Therapeutics venture capital transaction
Next: 9/14/2006: S5 Wireless venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs